Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor

Clinical trial NCT00638898 · COMPLETED

Trial details

NCT number: NCT00638898
Sponsor: City of Hope Medical Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Adult Central Nervous System Germ Cell Tumor Adult Rhabdomyosarcoma Childhood Central Nervous System Germ Cell Tumor Childhood Soft Tissue Sarcoma Ewing Sarcoma Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Ovarian Mixed Germ Cell Tumor Previously Untreated Childhood Rhabdomyosarcoma Recurrent Adult Brain Tumor Recurrent Adult Soft Tissue Sarcoma Recurrent Childhood Brain Stem Glioma

Start date: 2007-02-26
Primary completion: 2013-01-19
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.